PD-L1, fibrosis, and immunotherapy in hepatocellular carcinoma: the importance of a scientific method to explore observations and answer questions.

Grizzi, Fabio; Qehajaj, Dorina; Yiu, Daniel; Bresalier, Robert S; Chiriva-Internati, Maurizio

Grizzi, Fabio; Qehajaj, Dorina; Yiu, Daniel; Bresalier, Robert S; Chiriva-Internati, Maurizio.

Afiliação

Grizzi F; Department of Immunology and Inflammation, Humanitas Clinical and Research Center, Via Manzoni 56, Rozzano, 20089, Milan, Italy. fabio.grizzi@humanitasresearch.it.
Qehajaj D; Department of Immunology and Inflammation, Humanitas Clinical and Research Center, Via Manzoni 56, Rozzano, 20089, Milan, Italy.
Yiu D; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Bresalier RS; Division of Internal Medicine, Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer, Houston, TX, USA.
Chiriva-Internati M; Division of Internal Medicine, Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer, Houston, TX, USA.

Surg Today ; 50(10): 1318-1319, 2020 10.

Article em En | MEDLINE | ID: mdl-32002663

Assuntos

Carcinoma Hepatocelular; Neoplasias Hepáticas; Antígeno B7-H1; Carcinoma Hepatocelular/terapia; Fibrose; Humanos; Imunoterapia; Neoplasias Hepáticas/terapia

Palavras-chave

Cancer; Fibrosis; Immunotherapy; Liver; PD-L1

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Limite: Humans Idioma: En Revista: Surg Today Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Itália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google